Cellecta, Inc. Announces Upcoming Presentations on CRISPR and RNA Expression Profiling Technologies at AACR 2017

Booth #1721

28 Mar 2017
Lois Manton-O'Byrne, PhD
Executive Editor

Cellecta, Inc. has announced that it will deliver three scientific presentations at the upcoming American Association for Cancer Research (AACR) 2017 Annual Meeting. Cellecta researchers will present unpublished data on technology developments in genetic screens in human cancer cell lines using CRISPR-knockout, CRISPRi-repression, and CRISPRa-activation; as well as new data on applications of the Driver-Map targeted RNA expression solution for profiling immunity biomarkers and cellular composition analysis.

Details of the presentations are as follows:

Poster Abstract 403/ Poster 3: CRISPR/Cas9 genome-wide sgRNA libraries for loss-of-function and gain-of-function genetic screens
Session: Genomic Screening for Cancer Dependencies and Drug Response
Date and Time: Sunday, April 2, 2017, 1:00 - 5:00 p.m. Eastern Time
Location: Convention Center, Halls A-C, Poster Section 17

Spotlight Theatre Presentation: Driver-Map™ Assay: Gene expression profiling of protein-coding genes for tumor microenvironment analysis and biomarker discovery
Date and Time: Tuesday, April 4, 2017, 10:00 – 11:00 a.m. Eastern Time
Location: Convention Center, Spotlight Theatre B – Hall A

Poster Abstract 4652/ Poster 13: Profiling of immunity biomarkers in whole blood
Session: Diagnostic Biomarkers
Date and Time: Tuesday, April 4, 2017, 1:00 - 5:00 p.m. Eastern Time
Location: Convention Center, Halls A-C, Poster Section 28

Driver-Map Human Genome-Wide Targeted Expression Profiling Kit (24 reactions)

Cellecta

The DriverMap™ Human Genome-Wide Targeted Expression Profiling Assay enables researchers to simultaneously measure the expression level of almost 19,000 human protein-coding genes in a single assay. By combining highly multiplexed RT-PCR amplification with the depth and precision of next-generation sequencing (NGS) quantitation, the Driver-Map assay provides convenient, comprehensive, highly sensitive, and quantitative measurement of gene expression from total RNA. Don’t miss out on critical changes in gene expression. Capture the complete gene expression picture of your with Driver-Map targeted expression profiling kit. Easy-to-run, one-tube, single-day expression profiling directly from total RNA from any tissue, cell, or blood samples Efficient multiplex RT-PCR amplification for comprehensive profiles with greater detection of low abundant transcripts Robust, reproducible data from low-input RNA samples—start with as little as 10 pg total RNA

(0)

Links

Tags

Cellecta, Inc. Announces Upcoming Presentations on CRISPR and RNA Expression Profiling Technologies at AACR 2017